Overview: Insulin Antibodies TestIntroduction: The Insulin Antibodies Test detects insulin antibodies to diagnose autoimmune diabetes, causing high blood sugar or fatigue. Following 2023 ADA guidelines, it uses immunoassay for high specificity, supporting diabetes screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected type 1 diabetes or insulin resistance.
Other Names: Insulin Ab Assay, Autoimmune Diabetes Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Insulin antibody testing began in the 1970s with diabetes research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects insulin antibodies to diagnose autoimmune diabetes, guides treatment, and evaluates patients with high blood sugar or fatigue.
Test Parameters: 1. Insulin Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of high blood sugar, fatigue, or diabetes symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document high blood sugar, fatigue, weight loss, or family history of diabetes. Include current medications, especially insulin.
Consent: Written consent required, detailing the tests purpose, diabetes implications, and risks of blood or saliva collection.
Procedural Considerations: Uses immunoassay to detect insulin antibodies in serum or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for autoimmune diabetes diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Insufficient sample volume may reduce accuracy.
Clinical Significance: Positive insulin antibodies suggest type 1 diabetes or insulin autoimmune syndrome, guiding insulin therapy. Negative results may require further autoimmune testing.
Specialist Consultation: Consult an endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: GAD65 antibodies, HbA1c, or C-peptide to confirm autoimmune diabetes diagnosis.
Test Limitations: Not specific to type 1 diabetes; other autoimmune conditions may produce insulin antibodies. Clinical correlation is needed.
References: ADA Diabetes Guidelines, 2023; Diabetes Care, Atkinson MA, 2022.
